Enzyme replacement therapy with agalsidase beta improves cardiac involvement in Fabry's disease.
Fabry's disease is an X-linked lysosomal storage disease caused by a deficiency of alpha-galactosidase that results in an accumulation of neutral glycosphingolipids throughout the body, including the cardiovascular system.
Andreucci MV. +8 more
core
A 17-year-old boy with hemifacial flushing and anhidrosis. [PDF]
Farinha PS +3 more
europepmc +1 more source
Embryology and genetics of primary vesico-ureteric reflux and associated renal dysplasia [PDF]
Elisa Benetti +2 more
core +1 more source
A classical variant of ectodermal dysplasia: a case report. [PDF]
Jawade S +4 more
europepmc +1 more source
A novel pathogenic mutation in TSPEAR associated with sensorineural hearing loss: a case report and review of the literature. [PDF]
Ahmadkhani A +5 more
europepmc +1 more source
Porous polyethylene in reconstructive head and neck surgery [PDF]
Berghaus, Alexander
core +1 more source
Cutaneous manifestations of Fabry disease: A systematic review. [PDF]
Al-Chaer RN +4 more
europepmc +1 more source
Prenatal Identification of an EDA Variant in Dichorionic Male Twins: CfDNA Signal with Invasive Confirmation. [PDF]
Marcella S +14 more
europepmc +1 more source
Defining Histological Patterns in Inherited Ichthyoses: Toward a Diagnostic Algorithm Based on 66 Confirmed Cases. [PDF]
Süßmuth K +10 more
europepmc +1 more source
Parry-Romberg Syndrome: A Rare Case with Diagnostic Challenges and Orthodontic Implications. [PDF]
Patel S +4 more
europepmc +1 more source

